New Deal
Kenneth C. Frazier
Chairman and CEO at MERCK & CO
Manager
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (11)
Key Relationships
Announcement Date
Deal Value
Antelliq Group
Merck Animal Health
£2,922m
29 dealmakers
Immune Design
Merck & Co
£229m
6 dealmakers
Tilos Therapeutics
£606m
4 dealmakers
Merck & Co (women’s Health, Trusted Legacy Brands, And Biosimilars Businesses)
Institutional Investors
£5,390m
17 dealmakers
Staywell Company
Webmd Health Corp
value n/a
5 dealmakers
Themis Bioscience
37 dealmakers
Velosbio
£2,116m
55 dealmakers
ONCOIMMUNE
£319m
10 dealmakers
Seagen
£767m
Pandion Therapeutics
£1,308m
28 dealmakers
Alydia Health
Organon & Co
£174m
15 dealmakers